(Q37860938)

24 August 2017

1 reference

title

Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential (English)

1 reference

24 August 2017

1 reference

2

Brogden RN

1 reference

24 August 2017

Campoli-Richards DM

1

1 reference

24 August 2017

Faulds D

series ordinal

3

1 reference

24 August 2017

publication date

1 September 1990

1 reference

24 August 2017

1 reference

24 August 2017

volume

40

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

449-486

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199040030-00007

24 August 2017

exact match

0 references

cites work

Susceptibility of Hong Kong isolates of methicillin-resistant Staphylococcus aureus to antimicrobial agents

1 reference

12 December 2020

Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia

1 reference

12 December 2020

Bactericidal activity of teicoplanin in an in-vitro two-compartment kinetic model.

1 reference

12 December 2020

A comparison of the in-vitro activity of seventeen antibiotics against Streptococcus faecalis.

1 reference

12 December 2020

In-vitro activity of teicoplanin alone and in combination with rifampicin, gentamicin or tobramycin against coagulase-negative staphylococci

1 reference

12 December 2020

Uptake and activity of rifapentine in human peritoneal macrophages and polymorphonuclear leukocytes.

1 reference

12 December 2020

Surgical prophylaxis--the emerging picture

1 reference

12 December 2020

Treatment of Clostridium difficile-associated disease with teicoplanin

1 reference

12 December 2020

Efficacy of teicoplanin as antimicrobial treatment of severe nosocomial infections caused by gram-positive bacteria: a preliminary study

1 reference

12 December 2020

Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment

1 reference

12 December 2020

Comparison of intravenous teicoplanin with intramuscular amoxycillin for the prophylaxis of streptococcal bacteraemia in dental patients.

1 reference

12 December 2020

Comparison of efficacy and safety of teicoplanin in gram-positive infections: a multicentre study

1 reference

12 December 2020

Bactericidal activity and killing rate of serum in volunteers receiving teicoplanin alone or in combination with oral or intravenous rifampin

1 reference

12 December 2020

Intraventricular administration of teicoplanin in shunt associated ventriculitis caused by methicillin resistant Staphylococcus aureus

1 reference

12 December 2020

Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci

1 reference

12 December 2020

Clinical efficacy and safety of teicoplanin in the treatment of gram-positive infections

1 reference

12 December 2020

Staphylococcus epidermidis as a cause of postoperative wound infection after cardiac surgery: assessment of pathogenicity by a wound-scoring method.

1 reference

12 December 2020

Pharmacokinetics of teicoplanin in patients on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Pharmacokinetics of teicoplanin in subjects with varying degrees of renal function

1 reference

12 December 2020

Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results

1 reference

12 December 2020

Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin.

1 reference

12 December 2020

Teicoplanin-induced ototoxicity in Down's syndrome.

1 reference

12 December 2020

In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci

1 reference

12 December 2020

Beta-lactam antibiotics increase the frequency of plasmid transfer in Staphylococcus aureus.

1 reference

12 December 2020

Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria

1 reference

12 December 2020

The phannacokinetics and extravascular diffusion of teicoplanin in rabbits and comparative efficacy with vancomycin in an experimental endocarditis model

1 reference

12 December 2020

In vitro antistaphylococcal activity of teicoplanin and ciprofloxacin in peritoneal dialysis effluent

1 reference

12 December 2020

Evaluation of in vitro activity of teicoplanin against recent clinical isolates

1 reference

12 December 2020

Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256

1 reference

12 December 2020

Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations

1 reference

12 December 2020

[Treatment of septicemias and skin infections in burn patient by teicoplanin. Study of its skin diffusion]

1 reference

12 December 2020

Serum and tissue levels of teicoplanin during cardiac surgery: the effect of a high dose regimen

1 reference

12 December 2020

Teicoplanin in the therapy of staphylococcal neuroshunt infections

1 reference

12 December 2020

Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocci

1 reference

12 December 2020

A receptor-antibody sandwich assay for teicoplanin

1 reference

12 December 2020

Vancomycin-resistant enterococci

1 reference

12 December 2020

Therapeutic activity of teicoplanin on experimental listeriosis compared with that of vancomycin and ampicillin

1 reference

12 December 2020

In vitro interactions between teicoplanin and other antibiotics against enterococci and staphylococci

1 reference

12 December 2020

Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.

1 reference

12 December 2020

Antibiotic prophylaxis in cardiac surgery: a prospective comparison of two dosage regimens of teicoplanin with a combination of flucloxacillin and tobramycin

1 reference

12 December 2020

Evaluation of teicoplanin and vancomycin disk susceptibility tests

1 reference

12 December 2020

Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp.

1 reference

12 December 2020

Cellular uptake, and intracellular bactericidal activity of teicoplanin in human macrophages

1 reference

12 December 2020

Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics

1 reference

12 December 2020

Determination of teicoplanin concentration in serum using a bioassay technique.

1 reference

12 December 2020

In vitro activity of teicoplanin and vancomycin against anaerobes

1 reference

12 December 2020

Teicoplanin for therapy of gram-positive infections in neutropenic patients

1 reference

12 December 2020

Comparative in vitro study of teichomycin A2

1 reference

12 December 2020

Lessons learned from animal models of osteomyelitis

1 reference

12 December 2020

Treatment of bone and soft tissue infections with teicoplanin.

1 reference

12 December 2020

The structure and mode of action of glycopeptide antibiotics of the vancomycin group

1 reference

12 December 2020

The effect of medium and inoculum on the activity of vancomycin and teicoplanin against coagulase-negative staphylococci

1 reference

12 December 2020

Allergic cross-reactivity of teicoplanin and vancomycin

1 reference

12 December 2020

Prescribing aids for gentamicin

1 reference

12 December 2020

Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients

1 reference

12 December 2020

Bacterial biofilms in nature and disease

1 reference

12 December 2020

Teicoplanin in the treatment of infections by staphylococci, Clostridium difficile and other gram-positive bacteria

1 reference

12 December 2020

A comparative efficacy and safety study of teicoplanin plus aztreonam versus gentamicin plus piperacillin in haematology oncology patients with clinically diagnosed septicaemia

1 reference

12 December 2020

In vitro evaluation of teicoplanin and other antimicrobials against streptococci group D bacteria

1 reference

12 December 2020

In vitro activities of two oxazolidinone antimicrobial agents, DuP 721 and DuP 105.

1 reference

12 December 2020

Teicoplanin, its pharmacokinetics, blister and peritoneal fluid penetration

1 reference

12 December 2020

Options and limitations of teicoplanin in febrile granulocytopenic patients

1 reference

12 December 2020

A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients

1 reference

12 December 2020

A clinical trial on efficacy and safety of teicoplanin in combination with beta-lactams and aminoglycosides in the treatment of severe sepsis of patients undergoing allogeneic/autologous bone marrow transplantation

1 reference

12 December 2020

A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients

1 reference

12 December 2020

Pharmacokinetics of teicoplanin in pediatric patients

1 reference

12 December 2020

Teicoplanin administration in patients experiencing reactions to vancomycin

1 reference

12 December 2020

[Teicoplanin and Gram-positive coccus infections. Results of a multicenter study on 66 cases]

1 reference

12 December 2020

In vitro Activity of Teichomycin against Isolates of Gram-Positive Bacteria

1 reference

12 December 2020

Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections

1 reference

12 December 2020

Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection.

1 reference

12 December 2020

The use of a new glycopeptide antibiotic, teicoplanin, in the treatment of bacterial endocarditis

1 reference

12 December 2020

Teicoplanin in patients with chronic renal failure on dialysis: microbiological and pharmacokinetic aspects

1 reference

12 December 2020

Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients

1 reference

12 December 2020

Teicoplanin, a new antibiotic effective against gram-positive bacterial infections of the skin and soft tissues

1 reference

12 December 2020

Pharmacokinetics of teicoplanin in the elderly

1 reference

12 December 2020

Use of teicoplanin for Hickman catheter associated staphylococcal infection in immunosuppressed patients.

1 reference

12 December 2020

Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections

1 reference

12 December 2020

Teicoplanin-resistant coagulase-negative staphylococci

1 reference

12 December 2020

Teicoplanin compared to flucloxacillin for antibiotic treatment of neutropenic patients

1 reference

12 December 2020

Clinical efficacy and safety of teicoplanin

1 reference

12 December 2020

Efficacy and safety of teicoplanin in gram-positive peritonitis in patients on peritoneal dialysis

1 reference

12 December 2020

Bioassay for teicoplanin in peritoneal dialysis fluid

1 reference

12 December 2020

Teicoplanin in empirical combined antibiotic therapy of bacteraemias in bone marrow transplant patients

1 reference

12 December 2020

Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus

1 reference

12 December 2020

Comparison of the solid phase enzyme receptor assay (SPERA) and the microbiological assay for teicoplanin

1 reference

12 December 2020

Pharmacokinetics of teicoplanin in man after intravenous administration

1 reference

12 December 2020

Septicaemia due to Gram-positive cocci in cancer patients

1 reference

12 December 2020

Comparison of the in vitro activities of teicoplanin and vancomycin against Clostridium difficile and their interactions with cholestyramine.

1 reference

12 December 2020

Pharmacokinetics of teicoplanin in renal failure

1 reference

12 December 2020

Teicoplanin in the treatment of infection caused by gram-positive organisms

1 reference

12 December 2020

Clinical pharmacokinetics and tissue penetration of teicoplanin

1 reference

12 December 2020

Pharmacokinetics of teicoplanin in children

1 reference

12 December 2020

The effect of teicoplanin on leukocytic activity and intraleukocytic micro-organisms

1 reference

12 December 2020

Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus

1 reference

12 December 2020

Teicoplanin: Part 2. Evaluation of its use in the biliary system

1 reference

12 December 2020

The pharmacokinetics and tissue penetration of teicoplanin

1 reference

12 December 2020

In vitro activity of teichomycin compared with those of other antibiotics

1 reference

12 December 2020

Activity of glycopeptides against vancomycin-resistant gram-positive bacteria

1 reference

12 December 2020

Comparison of pharmacokinetics and bactericidal activity of teicoplanin and vancomycin

1 reference

12 December 2020

Bactericidal activity and killing rate of serum in volunteers receiving vancomycin or teicoplanin with and without amikacin given intravenously

1 reference

12 December 2020

Comparative activity of LY146032 against anaerobic cocci

1 reference

12 December 2020

The effect of antibiotic prophylaxis and topical antiseptics on the bacterial flora of the skin after cardiac surgery.

1 reference

12 December 2020

Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256.

1 reference

12 December 2020

Activity of teicoplanin compared with vancomycin alone, and combined with gentamicin, against penicillin tolerant viridans streptococci and enterococci causing endocarditis

1 reference

12 December 2020

A morphological study of bacterial colonisation of intravenous cannulae

1 reference

12 December 2020

Use of a glycopeptide antibiotic, teicoplanin, in the treatment of septicaemia caused by gram-positive bacteria

1 reference

12 December 2020

Determination of teicoplanin concentrations in serum by high-pressure liquid chromatography

1 reference

12 December 2020

Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria

1 reference

12 December 2020

Prevention of gram-positive and Candida albicans infections using teicoplanin and fluconazole: a randomized study in neutropenic children

1 reference

12 December 2020

A comparison of teicoplanin and cefuroxime as prophylaxis for orthopaedic implant surgery: a preliminary report.

1 reference

12 December 2020

Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis

1 reference

12 December 2020

Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties

1 reference

12 December 2020

Emergence of vancomycin resistance in coagulase-negative staphylococci

1 reference

12 December 2020

Glycopeptide antibiotics

1 reference

12 December 2020

Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open study.

1 reference

12 December 2020

Contamination of blood during cardiopulmonary bypass: the effect of antibiotic prophylaxis

1 reference

12 December 2020

The efficacy of the combination of teicoplanin or flucloxacillin with netilmicin in the treatment of Staphylococcus aureus bacteraemia

1 reference

12 December 2020

Antibiotic prophylaxis in cardiac surgery: serum and tissue levels of teicoplanin, flucloxacillin and tobramycin

1 reference

12 December 2020

Teicoplanin: Part 1. An evaluation of the concentrations seen in serum and the subcutaneous fat of the relatively ischaemic lower limb following a single intravenous bolus.

1 reference

12 December 2020

The intraocular penetration and retinal toxicity of teicoplanin.

1 reference

12 December 2020

Teicoplanin pharmacokinetics in patients with chronic renal failure.

1 reference

12 December 2020

A comparison of the responses of staphylococci and streptococci to teicoplanin and vancomycin.

1 reference

12 December 2020

The pharmacokinetics of teicoplanin in varying degrees of renal function

1 reference

12 December 2020

The potential impact on clinical practice of differences in the in-vitro activity of vancomycin and teicoplanin

1 reference

12 December 2020

Susceptibility of penicillin-sensitive and -resistant strains of Streptococcus pneumoniae to new antimicrobial agents, including daptomycin, teicoplanin, cefpodoxime and quinolones.

1 reference

12 December 2020

In vitro activity and human pharmacokinetics of teicoplanin

1 reference

12 December 2020

A study of the possible interactions between human platelets and the antibiotic MDL-507 (teicoplanin)

1 reference

12 December 2020

Prophylactic teicoplanin during insertion of Hickman catheters

1 reference

12 December 2020

A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria

1 reference

12 December 2020

Transferable vancomycin and teicoplanin resistance in Enterococcus faecium

1 reference

12 December 2020

Efficacy of teicoplanin in experimental group B streptococcal bacteremia and meningitis

1 reference

12 December 2020

Teicoplanin in the treatment of gram-positive-bacterial endocarditis

1 reference

12 December 2020

An outbreak of group A streptococcal skin infection: control by source isolation and teicoplanin therapy

1 reference

12 December 2020

Microbiological properties of teicoplanin

1 reference

12 December 2020

Pharmacokinetics of teicoplanin in critically ill patients with various degrees of renal impairment

1 reference

12 December 2020

Teicoplanin as a prophylactic antibiotic for dental bacteraemia

1 reference

12 December 2020

Poor efficacy of teicoplanin in treatment of deep-seated staphylococcal infections

1 reference

12 December 2020

A randomized prospective study of ceftazidime and ciprofloxacin with or without teicoplanin as an empiric antibiotic regimen for febrile neutropenic patients

1 reference

12 December 2020

Teicoplanin revisited

1 reference

12 December 2020

Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis

1 reference

12 December 2020

The antibiotic prophylaxis of infective endocarditis. Report of a working party of the British Society for Antimicrobial Chemotherapy

1 reference

12 December 2020

In vitro activity of teichomycin and vancomycin alone and in combination with rifampin

1 reference

12 December 2020

Third generation cephalosporins as a risk factor for Clostridium difficile-associated disease: a four-year survey in a general hospital.

1 reference

12 December 2020

Synergistic activity between vancomycin or teicoplanin and gentamicin or tobramycin against pathogenic diphtheroids

1 reference

12 December 2020

Susceptibility of Clostridium perfringens type A to 23 antimicrobial drugs

1 reference

12 December 2020

In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci

1 reference

12 December 2020

Pharmacokinetics of 14C-teicoplanin in healthy volunteers

1 reference

12 December 2020

Structure and mechanism of action of teicoplanin

1 reference

12 December 2020

Comparison of the in vitro antibacterial activity of teicoplanin and vancomycin against gram-positive cocci

1 reference

12 December 2020

Plastic devices: new fields for old microbes

1 reference

12 December 2020

Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with teicoplanin

1 reference

12 December 2020

Activity of teicoplanin against gram-negative anaerobes.

1 reference

12 December 2020

HPLC quantitation of the six main components of teicoplanin in biological fluids

1 reference

12 December 2020

Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.

1 reference

12 December 2020

In vitro activity of vancomycin and teicoplanin against anaerobic bacteria.

1 reference

12 December 2020

The in-vitro activity of ciprofloxacin in combination with other agents against anaerobes of clinical interest

1 reference

12 December 2020

Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin

1 reference

12 December 2020

Pharmacokinetics of [14C]teicoplanin in male rats after single intravenous dose

1 reference

12 December 2020

Teicoplanin for patients allergic to vancomycin

1 reference

12 December 2020

The activity of vancomycin and teicoplanin alone and in combination with gentamicin or ampicillin againstStreptococcus faecalis

1 reference

12 December 2020

Pharmacokinetics of single- and multiple-dose teicoplanin in healthy volunteers

1 reference

12 December 2020

In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci.

1 reference

12 December 2020

Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus

1 reference

12 December 2020

High pressure liquid chromatographic quantitation of teicoplanin in human serum

1 reference

12 December 2020

In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin

1 reference

12 December 2020

Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters

1 reference

12 December 2020

Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin

1 reference

12 December 2020

Antibiotic prophylaxis in cardiac surgery

1 reference

12 December 2020

Solid-phase enzyme-receptor assay (SPERA): a competitive-binding assay for glycopeptide antibiotics of the vancomycin class

1 reference

12 December 2020

Identification of fluorescent glycopeptide derivatives by two consecutive high pressure liquid chromatographic procedures

1 reference

12 December 2020

Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections

1 reference

12 December 2020

10.2165/00003495-199040030-00007

Identifiers

DOI

1 reference

24 August 2017

1 reference